Literature DB >> 7958541

Glycogen: its mode of formation and contribution to hepatic glucose output in postabsorptive humans.

W Pimenta1, N Nurjhan, P A Jansson, M Stumvoll, J Gerich, M Korytkowski.   

Abstract

To assess the relative contributions of gluconeogenesis and glycogenolysis to overall hepatic glucose output in postabsorptive normal humans and those of the indirect and direct pathways for glycogen synthesis, we studied six normal volunteers, who had been fasted for 16 h to reduce their hepatic glycogen stores, and then ingested glucose (250 g over 10 h) enriched with [6-3H] glucose to replenish and label their hepatic glycogen. After a 10-h overnight fast, release of the [6-3H] glucose into the circulation was traced with [2-3H] glucose to estimate breakdown of glycogen that had been formed via the direct pathway while gluconeogenesis was simultaneously estimated by incorporation of infused [14C] lactate into plasma glucose. We found that release of [6-3H] glucose into plasma (6.79 +/- 0.69 mumol.kg-1.min-1) accounted for 46 +/- 5% of hepatic glucose output (15.0 +/- 0.7 mumol.kg-1.min-1) while glucose formed from lactate (2.71 +/- 0.28 mumol.kg-1.min-1) accounted for 19 +/- 2% of hepatic glucose output. Since these determinations underestimate direct pathway glycogenolysis and overall gluconeogenesis, a maximal estimate for the contribution of indirect pathway glycogenolysis to hepatic glucose output is obtained by subtracting the sum of direct pathway glycogenolysis and lactate gluconeogenesis from hepatic glucose output. This amounted to a maximum of 36 +/- 5% of hepatic glucose output and 44 +/- 6% of overall glycogenolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958541     DOI: 10.1007/BF00417694

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  The simultaneous determination of C14 and H3 in the terminal groups of glucose.

Authors:  B BLOOM
Journal:  Anal Biochem       Date:  1962-01       Impact factor: 3.365

2.  A molecular order in the synthesis and degradation of glycogen in the liver.

Authors:  P Devos; H G Hers
Journal:  Eur J Biochem       Date:  1979-08-15

3.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

Authors:  D L Rothman; I Magnusson; L D Katz; R G Shulman; G I Shulman
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

Review 4.  Gluconeogenesis: methodological approaches in vivo.

Authors:  J L Chiasson; J E Liljenquist; W W Lacy; A S Jennings; A D Cherrington
Journal:  Fed Proc       Date:  1977-02

5.  Lactate turnover and gluconeogenesis in normal and obese humans. Effect of starvation.

Authors:  R A Kreisberg; L F Pennington; B R Boshell
Journal:  Diabetes       Date:  1970-01       Impact factor: 9.461

6.  On gluconeogenesis of human liver. Accelerated hepatic glucose formation induced by increased precursor supply.

Authors:  G Dietze; M Wicklmayr; K D Hepp; W Bogner; H Mehnert; H Czempiel; H G Henftling
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

7.  Rates of appearance and disappearance of plasma lactate after oral glucose: implications for indirect-pathway hepatic glycogen repletion in man.

Authors:  A Consoli; N Nurjhan; J Gerich
Journal:  Clin Physiol Biochem       Date:  1989

8.  Pathways of hepatic glycogen formation in humans following ingestion of a glucose load in the fed state.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  Metabolism       Date:  1989-06       Impact factor: 8.694

9.  Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man.

Authors:  A Consoli; F Kennedy; J Miles; J Gerich
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.

Authors:  D Kelley; A Mitrakou; H Marsh; F Schwenk; J Benn; G Sonnenberg; M Arcangeli; T Aoki; J Sorensen; M Berger
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

View more
  5 in total

1.  Glucose turnover and gluconeogenesis in human pregnancy.

Authors:  S Kalhan; K Rossi; L Gruca; E Burkett; A O'Brien
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Authors:  W H Martin; D J Hoover; S J Armento; I A Stock; R K McPherson; D E Danley; R W Stevenson; E J Barrett; J L Treadway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Contributions of gluconeogenesis to glucose production in the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.

Authors:  B Andersen; A Rassov; N Westergaard; K Lundgren
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.

Authors:  Birgitte Andersen; Niels Westergaard
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.